Acrongenomics Acquires Equity Stake in Molecu... (focused on applying its technology to th...)

Acrongenomics Acquires Equity Stake in Molecular Vision

Date:2/4/2008

focused on applying its technology to the medical diagnostics markets.

Important Information About Forward-Looking Statements

All statements in this news release that are other than statements of historical facts are forward-looking statements which contain our current expectations about our future results. Forward-looking statements involve numerous risks and uncertainties. We have attempted to identify any forward-looking statements by using words such as "anticipates", "believes", "could", "expects", "intends", "may", "should" and other similar expressions. Although we believe that the expectations reflected in all of our forward looking statements are reasonable, we can give no assurance that such expectations will prove to be correct. A number of factors may affect our future results and may cause those results to differ materially from those indicated in any forward-looking statements made by us or on our behalf. Such factors include our limited operating history; our need for significant capital to finance internal growth as well as strategic acquisitions; our ability to attract and retain key employees and strategic partners; our ability to achieve and maintain profitability; fluctuations in the trading price and volume of our stock; competition from other providers of similar products and services; and other unanticipated future events and conditions. For further information concerning risks and uncertainties that may affect our future results, please review the disclosures contained in our latest filings with the SEC, including our most recent annual report on Form 10-KSB, and subsequent quarterly reports on Form 10-QSB. Other than as required by federal securities laws, we undertake no obligation to publicly update or revise any of our forward-looking statements, whether as a result of changed circumstances, new information, future events, or for any other reason occurring after the date of this news release.

For more informat
'/>"/>

SOURCE Acrongenomics Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3
Related biology technology :

1. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
2. Neogen Acquires Kane Enterprises
3. OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company
4. Thermo Fisher Scientific Acquires Instrument Sales Business of Davis Inotek
5. United BioSource Acquires Interest in Leading Adaptive Design Technology Service Provider
6. NSF International Acquires David Begg Associates
7. United BioSource Acquires Caro Research, Leader in Simulation Modeling
8. Respironics Acquires Apollo Light Systems, Inc., Expands into Circadian Rhythm Device-Based Therapy Market
9. Thermo Fisher Scientific Acquires Logistics Provider to Strengthen Clinical Trials Management Services
10. Wyeth Pharmaceuticals Acquires Haptogen Ltd. to Boost Biotechnology Drug Discovery
11. Thermo Fisher Scientific Acquires Leader in Micro-Volume Spectrophotometers, NanoDrop Technologies

Post Your Comments:

(Date:12/16/2009)... -- Eppendorf has initiated an,import ban for ... for,infringement of European patent EP 1 179 ... the quantification of a target compound". The ... the respective products into any country of,the ... confiscate any,violating products. , ...

(Date:12/15/2009)... Dec. 15 Repligen Corporation (Nasdaq: ... received $731,000 in research funding to support the ... from the Muscular Dystrophy Association (MDA). This ... toxicology testing and GMP manufacture of a drug ... the MDA not only provides important funding for ...

(Date:12/15/2009)... for Atomic Force Microscopy (AFM) have been developed and are ... the liquid/air interface. The NeedleProbes’ cylindrical geometry enables researchers ... and viscosity - all in a single force distance curve. ... ... -- New, constant diameter NeedleProbes are enabling unique ...

(Date:12/15/2009)... -- Thomson Reuters today ... the first drug pipeline database to fully integrate ... highly anticipated new content is being provided to ... ,, Thomson Pharma will offer drug ... releases, conferences, and other sources across all therapeutic ...

Breaking Biology Technology:Eppendorf Successfully Initiates Import ban Against Nanosphere, Inc. for the Countries of the European Union 2 Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2 Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3 New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 2 New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 3 Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2

[0] Eppendorf Successfully Initiates Import ban Against Nanosphere, Inc. for the Countries of the European Union [0] Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program [0] New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM [0] Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials

... Ceres, Inc. announced today,that it has begun booking ... label. The highly anticipated launch marks the first seed,sales ... biofuels and biopower. The company simultaneously launched a Blade ... The company reported that the first Blade ...

... Cornerstone Therapeutics Inc. (Nasdaq: CRTX ), ... commercializing prescription medications for respiratory disorders, today provided ... activities following the closing of the business combination ... Inc. on October 31, 2008, and the renaming ...

... TORONTO, Dec. 11 /PRNewswire-FirstCall/ - GeneNews Limited (TSX: ... tests for the early detection of diseases and ... entered into a agreement allowing Centocor Research & ... osteoarthritis genomic biomarker program. Additional terms of the ...

Other Biology Technology:First Seed Sales of Dedicated Energy Crops Begin 2 First Seed Sales of Dedicated Energy Crops Begin 3 Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance 2 Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance 3 Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance 4 Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance 5 GeneNews provides Centocor access to its osteoarthritis program 2

First Seed Sales of Dedicated Energy Crops Begin Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance GeneNews provides Centocor access to its osteoarthritis program

(Date:12/15/2009)... a team of Spanish and American researchers found the fossil ... Huelva. Now they have published, for the first time, the ... the death of the young cetacean, possibly a baleen whale ... discovery of the partial fossil remains of a whale from ... Sands sedimentary formation, but it is the first time that ...

(Date:12/15/2009)... model organism, but there are currently few resources ... blood-forming tissues in this species. A newly ... from Cold Spring Harbor Laboratory Press fills this ... protocols for the preparation, enumeration, and microscopic examination ... tissues in the mouse. The laboratory manual ...

(Date:12/14/2009)... AlaskaScientists have identified a novel antifreeze molecule in a ... 100 degrees Fahrenheit. Unlike all previously described biological antifreezes ... little or no protein. It is composed of a ... new places within the cells of organisms. , ... this molecule is a whole new kind of antifreeze ...

[0] Story of 4.5 million-year-old whale unveiled in Huelva [0] New source of classical techniques for blood-based studies in the laboratory mouse [0] Scientists isolate new antifreeze molecule in Alaska beetle

... a few nights without enough sleep and you're more likely ... how sleep is related to the immune system. Now, researchers ... fruit flies can point to the answers. , What they ... may be a two-way street: sick flies can't sleep, and ...

... Researchers observing wild chimpanzees in Uganda have discovered repeated ... infanticide. The findings, reported by Simon Townsend, Katie Slocombe ... and the Budongo Forest Project, Uganda, appear in the ... by Cell Press. , Infanticide is known to occur ...

... early or localized prostate cancer, taking too many multivitamins ... or fatal prostate cancers, according to a study in ... the National Cancer Institute . , Millions of Americans ... health benefits, even though there is limited scientific evidence ...

Other Biology News:Sleepless for science: Flies show link between sleep, immune system in Stanford study 2 Sleepless for science: Flies show link between sleep, immune system in Stanford study 3 Female-led infanticide in wild chimpanzees 2 Heavy multivitamin use may be linked to advanced prostate cancer 2

Sleepless for science: Flies show link between sleep, immune system in Stanford study Female-led infanticide in wild chimpanzees Heavy multivitamin use may be linked to advanced prostate cancer

...

Chicken Aortic Smooth Muscle Cells (CAOSMC) (>500,000 cells)...

Canine Chondrocytes (CnC) (500,000 cells)...

B-FABP (FL-132)...

Biology Products:

HEPA Filtered Single Chamber Water Jacketed Incubator, CO2/O2 IR, 115V, 50/60 Hz from Thermo Scientific CAOSMC (C354-05) from European Collection of Cell Cultures (ECACC)CnC (Cn402-05) from European Collection of Cell Cultures (ECACC)Rabbit Anti-B-FABP (FL-132) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.

Acrongenomics Acquires Equity Stake in Molecu...(focused on applying its technology to th...)